289 related articles for article (PubMed ID: 20661220)
21. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
22. Heparanase, TrkC and p75NTR: their functional involvement in human medulloblastoma cell invasion.
Sinnappah-Kang ND; Kaiser AJ; Blust BE; Mrak RE; Marchetti D
Int J Oncol; 2005 Sep; 27(3):617-26. PubMed ID: 16077909
[TBL] [Abstract][Full Text] [Related]
23. MCM7 amplification and overexpression are associated with prostate cancer progression.
Ren B; Yu G; Tseng GC; Cieply K; Gavel T; Nelson J; Michalopoulos G; Yu YP; Luo JH
Oncogene; 2006 Feb; 25(7):1090-8. PubMed ID: 16247466
[TBL] [Abstract][Full Text] [Related]
24. Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma.
Lee YS; Ha SA; Kim HJ; Shin SM; Kim HK; Kim S; Kang CS; Lee KY; Hong OK; Lee SH; Kwon HS; Cha BY; Kim JW
Exp Mol Pathol; 2010 Feb; 88(1):138-42. PubMed ID: 19818763
[TBL] [Abstract][Full Text] [Related]
25. An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma.
Kongkham PN; Northcott PA; Ra YS; Nakahara Y; Mainprize TG; Croul SE; Smith CA; Taylor MD; Rutka JT
Cancer Res; 2008 Dec; 68(23):9945-53. PubMed ID: 19047176
[TBL] [Abstract][Full Text] [Related]
26. Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma.
Traenka C; Remke M; Korshunov A; Bender S; Hielscher T; Northcott PA; Witt H; Ryzhova M; Felsberg J; Benner A; Riester S; Scheurlen W; Grunewald TG; von Deimling A; Kulozik AE; Reifenberger G; Taylor MD; Lichter P; Butt E; Pfister SM
Cancer Res; 2010 Oct; 70(20):8003-14. PubMed ID: 20924110
[TBL] [Abstract][Full Text] [Related]
27. Mitogenic effects of the up-regulation of minichromosome maintenance proteins in anaplastic thyroid carcinoma.
Guida T; Salvatore G; Faviana P; Giannini R; Garcia-Rostan G; Provitera L; Basolo F; Fusco A; Carlomagno F; Santoro M
J Clin Endocrinol Metab; 2005 Aug; 90(8):4703-9. PubMed ID: 15899946
[TBL] [Abstract][Full Text] [Related]
28. Low-level copy gain versus amplification of myc oncogenes in medulloblastoma: utility in predicting prognosis and survival. Laboratory investigation.
Takei H; Nguyen Y; Mehta V; Chintagumpala M; Dauser RC; Adesina AM
J Neurosurg Pediatr; 2009 Jan; 3(1):61-5. PubMed ID: 19119907
[TBL] [Abstract][Full Text] [Related]
29. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
30. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.
Shohet JM; Hicks MJ; Plon SE; Burlingame SM; Stuart S; Chen SY; Brenner MK; Nuchtern JG
Cancer Res; 2002 Feb; 62(4):1123-8. PubMed ID: 11861392
[TBL] [Abstract][Full Text] [Related]
31. RBM5 Acts as Tumor Suppressor in Medulloblastoma through Regulating Wnt/β-Catenin Signaling.
Yu J; Ji G; Shi W; Zhao R; Shen W; Zheng J; Li H; Jiang F
Eur Neurol; 2020; 83(3):242-250. PubMed ID: 32610314
[TBL] [Abstract][Full Text] [Related]
32. Deregulated minichromosomal maintenance protein MCM7 contributes to oncogene driven tumorigenesis.
Honeycutt KA; Chen Z; Koster MI; Miers M; Nuchtern J; Hicks J; Roop DR; Shohet JM
Oncogene; 2006 Jul; 25(29):4027-32. PubMed ID: 16518415
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of minichromosome maintenance protein 7 as a prognostic marker in canine cutaneous mast cell tumours.
Berlato D; Stewart J; Newton R; Maglennon GA; Monti P; Flindall A; Murphy S
Vet Comp Oncol; 2012 Jun; 10(2):135-42. PubMed ID: 22235877
[TBL] [Abstract][Full Text] [Related]
34. Role of Rac1-regulated signaling in medulloblastoma invasion. Laboratory investigation.
Zavarella S; Nakada M; Belverud S; Coniglio SJ; Chan A; Mittler MA; Schneider SJ; Symons M
J Neurosurg Pediatr; 2009 Aug; 4(2):97-104. PubMed ID: 19645540
[TBL] [Abstract][Full Text] [Related]
35. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
[TBL] [Abstract][Full Text] [Related]
36. Minichromosome maintenance proteins are useful adjuncts to differentiate between benign and malignant melanocytic skin lesions.
Gambichler T; Shtern M; Rotterdam S; Bechara FG; Stücker M; Altmeyer P; Kreuter A
J Am Acad Dermatol; 2009 May; 60(5):808-13. PubMed ID: 19389522
[TBL] [Abstract][Full Text] [Related]
37. Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway.
Hsieh MJ; Chen KS; Chiou HL; Hsieh YS
Eur J Cell Biol; 2010 Aug; 89(8):598-606. PubMed ID: 20434230
[TBL] [Abstract][Full Text] [Related]
38. Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy.
Sanchez-Diaz PC; Burton TL; Burns SC; Hung JY; Penalva LO
BMC Cancer; 2008 Sep; 8():280. PubMed ID: 18826648
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of survivin splice isoforms in medulloblastomas.
Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009
[TBL] [Abstract][Full Text] [Related]
40. HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth.
Milde T; Oehme I; Korshunov A; Kopp-Schneider A; Remke M; Northcott P; Deubzer HE; Lodrini M; Taylor MD; von Deimling A; Pfister S; Witt O
Clin Cancer Res; 2010 Jun; 16(12):3240-52. PubMed ID: 20413433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]